Corpus Luteal and ART
-
StatusAccepting Candidates
-
Age-
-
Sexes
-
Healthy Volunteers
Details
| Full study title | Setmelanotide (RM-493) Phase 2 Treatment Trial in Patients with rare genetic disorders of obesity |
| Protocol number | OCR14631 |